FASN and esophageal squamous cell carcinoma: circHIPK3 acts as a ceRNA by sponging miR-637 to upregulate FASN expression and fatty acid biosynthesis of ESCC cells, indicating circHIPK3/miR-637/FASN axis as a promising therapeutic target for anti-ESCC strategy (Cao et al., 2024).